30
Sep
2009
Looking for Some of This?
Posted in My Rants
[Update | Add Domain Associates, Domain Partners, VIII $500M to the early-stage drug and device sectors; bringing recently closed funds up to $1,925M]
Recently Boston, MA-based Excel Venture Management announced the close of the new $125M Excel Medical Fund. The portfolio is a planned balance across healthcare IT and services, diagnostics, and medical devices, plus life [...]
28
Sep
2009
Hot off the press! (and, better late than never…) The July 2009 OnBioVC | Trend Analysis study is now available for FREE via download [HERE]. Over $668M flowed into early-stage biopharma, diagnostic and device companies in the seventh month of 2009 and over $3,821M year-to-date! Find out who is investing in what and where.
Word on [...]
27
Sep
2009
Now, some 48-hours later, it may be considered old news that Allos Therapeutics (NASDAQ: ALTH) received from FDA accelerated approval for Folotyn™ (pralatrexate) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Folotyn™ is the first and only drug approved by FDA for PTCL and represents a new treatment option for [...]
24
Sep
2009
Tape-Delay from the RMLSIC | 3 of 4
Posted in AZ Private: Medipacs, AZ Private: Regenesis, CO Private: BiOptix, CO Private: Medivance, CO Private: ValveXchange, UT Private: Coherex, UT Private: Numira, UT Private: ThermImage
Today’s third of four installments covering the Rocky Mountain Life Science Investor Conference focuses on the medical device presenting companies. In addition, here are some links to the additional coverage:
Part I – The Dx companies [HERE]Part II – The Biopharma companies [HERE]Part iV – Summary [In the Works]
BiOptix – Boulder, CO-based BO has developed a [...]
23
Sep
2009
Commercial-stage Snoasis Medical (Denver, CO) is focused on the development and commercialization of products which redefine the way clinicians perform perioplastic surgery. The core technology behind Snoasis Medical’s current product offering is placental tissue. These placental tissue products are believed to be the first of its kind for dental applications and possess features and benefits [...]
22
Sep
2009
CLSDF continues to maintain keen watch on the thawing of the public equity markets, calibrated in a semi-quantitative approach via the life science IPO pricings. If all three of the current filings get out priced ‘as-is’ I would then call the score FINANCING EVENT 3 & LIQUIDITY OPPORTUNITY 2. A nice balance and it makes [...]
21
Sep
2009
Tape-Delay from the RMLSIC | Part Deux
Posted in CO Private: ApopLogic, CO Private: BioAmps, CO Private: GlobeImmune, CO Private: InViragen, CO Private: Myocept, CO Private: Western, CO Private: miRagen, MT Private: LigoCyte
Continuing here with Part Deux of the Rocky Mountain Life Science Investor Conference presenting companies. Yesterday CLSDF posted the Diagnostic oriented entities, today we feature the biopharma folks.
ApopLogic – Aurora, CO-based AL is a biopharmaceutical company focused on the discovery, and development of therapeutic products that target apoptotic cell death pathways found in cancers, leukemias [...]
21
Sep
2009
FDA 2.0…Really?
Posted in My Rants
Now this is interesting! The Food and Drug Administration’s Center for Drug Evaluation and Research, in collaboration with FDA’s Center for Biologics Evaluation and Research, Center for Veterinary Medicine, and Center for Devices and Radiological Health, has announced a public hearing (scheduled for 12 & 13 November in Washington DC) to discuss issues related to [...]
20
Sep
2009
Tape-Delay from the RMLSIC | Part I
Posted in AZ Private: Applied Microarrays, AZ Private: HTG, CO Private: Beacon Biotech, CO Private: Biodesix, NM Private: nanoMR, TX Private: Castle Bio, UT Private: Axial Biotech, UT Private: LineaGen
I had the best intentions of bringing up to the minute information flowing through CLSDF from the content rich Rocky Mountain Life Science Investor Conference however, during the first company presentation slot it quickly became apparent that due to the richness of the subject matter in order to keep up I had to turn off [...]
20
Sep
2009
EJ BioMed, a spin-off from Ft. Collins, CO-based Eldon James Corporation, who focuses on production of critical use components for medical devices, recently announced an exclusive supplier deal with Stryker (NYSE: SYK) to design and produce tubing and fittings for next-gen Stryker Medical hospital mattresses. The new 105-pod cushion matrix mattress was developed to prevent [...]
16
Sep
2009
Live Blogging from the RMLSIC
Posted in My Rants
UPDATE (Breakfast) – Roy Davis, VP Corporate Development at Johnson & Johnson (NYSE: JNJ) and President JNJ Development Corporation opened the first full day of the RMLIC. He focused on “Creating New Business Opportunities at Johnson & Johnson” and stressed how a targeted focus on fostering innovation outside the entity (in addition to internal development) [...]
16
Sep
2009
15
Sep
2009
Recall that Steven Dow, DVM, Ph.D., Professor in the departments of Clinical Sciences and Pathology in the College of Veterinary Medicine at Colorado State University, co-founded Juvaris Biotherapeutics.
Good or bad, Juvaris is now a Burlingame, CA-based biotechnology company, developing adjuvanted vaccines for infectious diseases. Recently a definitive agreement with Antigen Discovery, Inc. was announced [...]
Life Science Deal Flow PARTNERS
-
